Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
About this trial
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient over the age of 18;
Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
Patient agree will all study procedure : biological samples & tissues samples
Disqualifiers
Patient not affiliated to Social Protection system
Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
The level of French is insufficient to consent to the study and to response to the questionnaires
Patient under guardianship
Trial design
Design model
Single group
Treatments tested in this trial
biological collection
Biological/VaccineBlood samples collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression
Tissues collections
Other interventionTumours and not tumours tissues will be collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression
Treatment groups
600 Participants
are divided into 1 treatment groupGroup A: Tumors and blood collectionExperimental treatment 2 interventions
Trial outcomes
Primary outcomes
1
Proportion of patients who gave their consent to participate in the study
The proportion of patients who consent to participate in the study among the screened patients
Time frame
Until the study completion: 4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov